If something is going wrong right now — what to do, and what to tell an ER
What Did You Take

Compounds

Twelve compounds, chosen because the honest answer differs sharply from the marketing answer and the harm is real. Each page leads with what the compound actually does for the person taking it, because a page that opens with a warning is a page nobody finishes.

All twelve compounds, sorted by verdict band.
Compound Verdict DependenceAcute toxicityDocumented harmLong-term riskEvidence qualityProduct integrity
Creatine Well-characterised, low concern Dependence liability: 1 out of 5 Acute toxicity: 1 out of 5 Documented serious harm: 1 out of 5 Long-term / irreversible risk: 1 out of 5 Evidence quality: 5 out of 5 Product integrity risk: 2 out of 5
Kratom Works as advertised, real trade-offs Dependence liability: 4 out of 5 Acute toxicity: 3 out of 5 Documented serious harm: 4 out of 5 Long-term / irreversible risk: 2 out of 5 Evidence quality: 3 out of 5 Product integrity risk: 4 out of 5
LGD-4033 Works as advertised, real trade-offs Dependence liability: 1 out of 5 Acute toxicity: 2 out of 5 Documented serious harm: 3 out of 5 Long-term / irreversible risk: 3 out of 5 Evidence quality: 3 out of 5 Product integrity risk: 5 out of 5
MK-677 Works as advertised, real trade-offs Dependence liability: 1 out of 5 Acute toxicity: 2 out of 5 Documented serious harm: 2 out of 5 Long-term / irreversible risk: 3 out of 5 Evidence quality: 4 out of 5 Product integrity risk: 4 out of 5
Ostarine Works as advertised, real trade-offs Dependence liability: 1 out of 5 Acute toxicity: 2 out of 5 Documented serious harm: 3 out of 5 Long-term / irreversible risk: 3 out of 5 Evidence quality: 3 out of 5 Product integrity risk: 5 out of 5
BPC-157 Largely unknown Dependence liability: 1 out of 5 Acute toxicity: 2 out of 5 Documented serious harm: 1 out of 5 Long-term / irreversible risk: 3 out of 5 Evidence quality: 1 out of 5 Product integrity risk: 5 out of 5
Gray-market GLP-1s Serious risk Dependence liability: 1 out of 5 Acute toxicity: 4 out of 5 Documented serious harm: 3 out of 5 Long-term / irreversible risk: 2 out of 5 Evidence quality: 4 out of 5 Product integrity risk: 5 out of 5
Melanotan II Serious risk Dependence liability: 1 out of 5 Acute toxicity: 3 out of 5 Documented serious harm: 4 out of 5 Long-term / irreversible risk: 4 out of 5 Evidence quality: 1 out of 5 Product integrity risk: 5 out of 5
RAD-140 Serious risk Dependence liability: 1 out of 5 Acute toxicity: 2 out of 5 Documented serious harm: 4 out of 5 Long-term / irreversible risk: 4 out of 5 Evidence quality: 2 out of 5 Product integrity risk: 5 out of 5
Cardarine The evidence says don’t Dependence liability: 1 out of 5 Acute toxicity: 1 out of 5 Documented serious harm: 2 out of 5 Long-term / irreversible risk: 5 out of 5 Evidence quality: 2 out of 5 Product integrity risk: 4 out of 5
Phenibut The evidence says don’t Dependence liability: 5 out of 5 Acute toxicity: 4 out of 5 Documented serious harm: 4 out of 5 Long-term / irreversible risk: 2 out of 5 Evidence quality: 2 out of 5 Product integrity risk: 4 out of 5
Tianeptine The evidence says don’t Dependence liability: 5 out of 5 Acute toxicity: 4 out of 5 Documented serious harm: 5 out of 5 Long-term / irreversible risk: 2 out of 5 Evidence quality: 3 out of 5 Product integrity risk: 5 out of 5

Every score is 1–5 and higher always means more of that dimension. Evidence quality is the one that reads backwards: a high score there means well studied, not safe. How we rate, and how to challenge a rating.

Well-characterised, low concern (1 of 5)

Studied properly, used widely, and the honest answer is that it is broadly fine.

Works as advertised, real trade-offs (2 of 5)

It does the thing people take it for, and it costs something specific and known.

Largely unknown (3 of 5)

Promising or popular, but the human evidence to judge it does not exist yet.

Serious risk (4 of 5)

Documented harm in humans that is severe, common, or hard to see coming.

The evidence says don’t (5 of 5)

The known downside is severe enough that we will say it plainly rather than hedge.

What is not here

There are well over a hundred compounds sold in this space. This site covers twelve, and will not expand until all twelve have been reviewed by a clinician and are being kept current. One page that is accurate and up to date is worth more than forty that are neither — to you, to a search engine, and to a language model answering your question on our behalf.

If a compound you are looking for is missing, that is not a judgement that it is safe. It means we have not done the work yet and would rather say so.